» Articles » PMID: 26731971

Adverse Drug Reactions in Hospitalized Cardiac Patients: Characteristics and Risk Factors

Overview
Specialty Emergency Medicine
Date 2016 Jan 7
PMID 26731971
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: Adverse drug reactions (ADRs) appear more frequently than actually reported and registered. The main goal of our work was to analyze risk factors, incidence and characteristics of ADRs in hospitalized cardiac patients.

Methods: This prospective study included 200 patients, hospitalized at Cardiology Center of the Clinical Centre of Montenegro. ADRs were collected using specially designed questionnaire, based on the list of symptoms and signs that could point out to potential ADRs. Data from medical charts of patients, lab tests and other available parameters were observed and combined with the data from questionnaire. Severity of ADRs were assessed as serious or nonserious according to the World Health Organization criteria. Causality was assessed using the Naranjo probability scale.

Results: A total of 34% of all the patients experienced at least one ADR. The most common ADRs occurred as nervous system disorders, less frequent were cardiovascular disorders, while the immune system disorders were the rarest. Sixteen percent of all ADRs were characterized as serious, most often caused by carvedilol and amiodarone. The majority of patients (97.3%) recovered without consequences. The multivariate analysis showed independent significant associations between ADRs and age, gender, comorbidities and polypragmasia.

Conclusion: ADRs represent a significant issue in hospitalized cardiac patients population. The most significant predictors for ADRs in observed population were age, comorbidity, number of medications used during hospitalization and patients' gender. Preventive measures such as pharmacotherapy rationalization and continual education of health care professionals could reduce the frequency of ADRs appearance in patients with detected risk factors.

Citing Articles

Intervention of pharmacist included in multidisciplinary team to reduce adverse drug event: a qualitative systematic review.

Zaij S, Pereira Maia K, Leguelinel-Blache G, Roux-Marson C, Kinowski J, Richard H BMC Health Serv Res. 2023; 23(1):927.

PMID: 37649018 PMC: 10470127. DOI: 10.1186/s12913-023-09512-6.


Risk factors for adverse drug reactions associated with clopidogrel therapy.

Mugosa S, Radosavljevic I, Sahman M, Djordjevic N, Todorovic Z Open Med (Wars). 2022; 17(1):694-701.

PMID: 35480401 PMC: 8990878. DOI: 10.1515/med-2021-0371.


Potential drug-drug interactions associated with clinical and laboratory findings at hospital admission.

Kovacevic M, Kovacevic S, Radovanovic S, Stevanovic P, Miljkovic B Int J Clin Pharm. 2019; 42(1):150-157.

PMID: 31865593 DOI: 10.1007/s11096-019-00951-y.


Categorization and association analysis of risk factors for adverse drug events.

Zhou L, Rupa A Eur J Clin Pharmacol. 2017; 74(4):389-404.

PMID: 29222712 DOI: 10.1007/s00228-017-2373-5.


Imputation of adverse drug reactions: Causality assessment in hospitals.

Varallo F, Planeta C, Herdeiro M, Mastroianni P PLoS One. 2017; 12(2):e0171470.

PMID: 28166274 PMC: 5293251. DOI: 10.1371/journal.pone.0171470.